Acomplia is a drug also known as Rimonabant was discovered and developed by French pharmaceutical company Sanofi-Aventis. This drug is currently showing immense promise in the field of the treatment for obesity and help in the stopping of smoking.

This experimental drug will help obese people lose weight, stop smoking and also help in protecting the heart. Recent trials have shown that 33 percent of people taking Rimonabant lost 10 percent of body weight and kept their weight down for two years which is a record that no other diet drug can claim. This will help in saving some people who are at risk for heart problems due to being over weight.

As well as keeping a person lean and slim, the diet drug also helps a person to stop smoking. This is a bonus and will be of great interest for many smokers who are afraid to give up because they say they are afraid they will put on weight. It is known that there are diseases associated with smoking and taking Acomplia can reduce these risks. People were able to quit and stay off cigarettes significantly better using Acomplia and also not gain all that weight that generally happens when a person stops smoking. This is an added benefit to losing weight and quitting smoking.

Studies have shown that there are nerve receptors that exist in the brain and fat cells. It is these receptors encourage the people to overeat and intake nicotine. The action of Acomplia blocks the signals from these receptors and prevents them from encourages us to overeat. Addicted smokers and people who overeat have very active receptors of this kind and by blocking the signals, the overeater or smoker loses the urge to eat or smoke thus helping them to live healthier lives.

Acomplia is a unique drug that can help you stop smoking and overeating. Statistics from the National Health Association smoking and being over weight are two of this decades largest health concerns. Taking Acomplia may help overcome both of these health issues promoting a healthier future.